Your Health. Your Family. Your Choice.
|History of Changes from the VAERS Wayback Machine|
|Vaccination / Manufacturer||Lot / Dose||Site / Route|
|COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH||- / 2||- / -|
Administered by: Other Purchased by: ??
Symptoms: Arthralgia, Chills, Fatigue, Feeling abnormal, Flatulence, Headache, Hyperhidrosis, Vaccination site pain
Life Threatening? No
Birth Defect? No
Permanent Disability? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Other Medications: Pfizer, Inc. EUA 027034; Pfizer, Inc. EUA 027034; Pfizer, Inc. EUA 027034; Pfizer, Inc. EUA 027034
Preexisting Conditions: Medical History/Concurrent Conditions: Pain; Perforation; Pins and needles; Surgery (Experienced a perforated duodenum in 2017)
Diagnostic Lab Data:
CDC 'Split Type': GBPFIZER INC202101211425
Write-up: hours; approx; injection site bled then pain at the site almost immediately; Joint pain; Sweating; Chills; Flatulence; Pain injection site; Fatigue; This is a spontaneous report from a contactable consumer. This is a report received from the regulatory authority. Regulatory authority report number GB-MHRA-WEBCOVID-202109142144298530-SLVD0, Safety Report Unique Identifier GB-MHRA-ADR 25941691. A 50-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE; Formulation: solution for injection, Lot number: not reported), dose 2 via an unspecified route of administration on 13Sep2021 (age at the time of vaccination 50-year-old) as DOSE 2, SINGLE for covid-19 immunization. Historical vaccine included first dose of bnt162b2 (Lot Number: not reported) via an unspecified route of administration on unspecified date as DOSE 1, SINGLE for covid-19 immunization. Medical history included surgery from 2017 to 2017 (experienced a perforated duodenum in 2017 and required emergency surgery and life support in ITU (4 day stay in ITU)), pins and needles, pain and perforation from an unknown date and unknown if ongoing. Unsure if patient has had symptoms associated with COVID-19. Not had a COVID-19 test. Patient had not tested positive for COVID-19 since having the vaccine. Patient was not enrolled in clinical trial. Concomitant medications included amitriptyline taken for pins and needles; buprenorphine (BUTEC) taken for pain; desogestrel (CERAZETTE [DESOGESTREL]) taken for an unspecified indicatpiion and lansoprazole taken for perforation all start date and stop date were not provided. On an unspecified date, the patient experienced hours, approx, injection site bled then pain at the site almost immediately. On 13Sep2021, patient experienced pain injection site, increasing in intensity. Sweating begun approx 2 hours after vaccination followed by flatulence, fatigue, chills (all within 6 hours). As 24hrs later (on 14Sep2021) came joint pain with fatigue, chills and sweating coming in waves. All the events were assessed as medically significant. The outcome of hours, approx, injection site bled then pain at the site almost immediately was recovered on an unspecified date and other events pain injection site, fatigue, joint pain, sweating, chills, flatulence were not recovered. No follow-up attempts are possible, Information about Batch/Lot Number cannot be obtained. No further information is expected.
Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166